OrbiMed Israel BioFund GP Limited Partnership 13D and 13G filings for NOVUS THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-18 4:35 pm Unchanged | 2020-08-14 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.400% | 0 (Unchanged) | Filing |